SAREPTA THERAPEUTICS INC
DBCV 1.500%11/1
CUSIP: 803607AB6
Institutional Holders — Q4 25
| Manager | Alpha | Flow | Value | Shares | Change |
|---|
Implied Institutional Price History
Estimated from 13F aggregate market value ÷ shares reported across all institutional filers. Reflects quarter-end snapshot, not actual trade prices.
| Quarter | Filers | Institutional Value | Shares Held | Est. Avg Price |
|---|---|---|---|---|
| Q3 24 | 17 | $0.10B | 59,114,000 | $1.71 |
| Q2 24 | 17 | $0.13B | 59,044,000 | $2.16 |
| Q1 24 | 19 | $0.11B | 62,234,000 | $1.79 |
| Q4 23 | 23 | $0.09B | 63,387,300 | $1.42 |
| Q3 23 | 20 | $0.11B | 63,691,300 | $1.78 |
| Q2 23 | 24 | $0.11B | 70,593,000 | $1.55 |
| Q1 23 | 25 | $0.11B | 60,371,268 | $1.74 |
| Q4 22 | 42 | $0.77B | 412,338,304 | $1.88 |
Source: SEC 13F-HR filings. Implied price = aggregate market value ÷ shares reported. Not investment advice.